News

Podcast

Insights from a Pharmacy Times Peer Exchange: ADC Drug Design and HER2 Ultra-Low Breast Cancer Indiciations

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacists discuss how drug design impacts drug efficacy and indications for HER2-low and -ultra-low breast cancer.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Inflammation concept, inflammated human tissues 3d rendering - Image credit: picture-waterfall | stock.adobe.com
Austin Texas | Image credit: Kevin Ruck - stock.adobe.com
Related Content
digital representation of car t cells targeting lymphoma cells vibrant and scientific lymphoma car t cell therapy for lymphoma
June 30th 2025

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Luke Halpern, Assistant Editor
An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
July 1st 2025

An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Illustration of bone marrow fibrosis | Image Credit: © AImmersive Imagery - stock.adobe.com
June 30th 2025

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

Alexandra Gerlach, Associate Editor
Pharmacy Times, Pharmacy Focus Oncology Edition
June 27th 2025

Allen's Story: The Promising Potential of Intratumoral Immunotherapy

Alexandra Gerlach, Associate Editor
ASCO 2025: How AI-Powered Tools Are Reshaping Oncology Data Capture and Clinical Decision-Making
June 30th 2025

ASCO 2025: How AI-Powered Tools Are Reshaping Oncology Data Capture and Clinical Decision-Making

Gayathri Namasivayam, PhD Alana Hippensteele, Lead Editor
Respiratory Virus Genetic Material Micrograph - Image credit: GOLVR | stock.adobe.com
June 30th 2025

Study Sheds Light on Impact of Vaccination, Infection on Anti-RSV IgG Levels

Kennedy Ferruggia, Assistant Editor